BioTechniques

Accelerating drug discovery with “paradigm shifting” AI model

A new tool that uses machine learning for drug discovery predicts how molecules will influence gene expression.
BioTechniques

How GLP-1 agonists affect gene expression and promote pancreatic health

Researchers discover a protein that connects GLP-1 drugs to long-term, broad genomic responses that can promote pancreatic ...
Business Wire

Akamis Bio Announces Publication Detailing Initial Proof of Mechanism for NG-350A, an IV-Dosed Tumor Gene Therapy Delivering a CD40 Agonist Payload

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Akamis Bio, a clinical-stage oncology company using a proprietary Tumor-Specific Immuno-Gene Therapy (T-SIGn®) platform to deliver novel immunotherapeutic proteins, ...
GEN

Gene Syntax Guidelines to Increase Expression and Predictability

Sizeable differences in gene expression means and ratios—based solely upon where genes are located on a plasmid (gene syntax)—have been discovered by researchers at Dartmouth College. This new ...
Morning Overview on MSN

Some bacteria use CRISPR-like tools to switch genes on

Researchers have found that certain bacteria carry a naturally occurring system, built from repurposed CRISPR components, ...
BioWorld

Poly(A) tail mimetics boost gene expression in haploinsufficiency models

BioWorld - Sunday, April 5, 2026 Breaking News: Best of BioWorld Science: Q1 See today's BioWorld Science Home » Poly (A) tail mimetics boost gene expression in haploinsufficiency models To read the ...
GEN

Akamis Bio Raises $60 Million for Cancer Gene Therapy, Signs Licensing Deal with Xuanzhu Biopharma

Akamis Bio, a clinical-stage oncology company, has raised $60 million in Series A funding that will drive continued development of NG-350A, a new gene therapy based on its proprietary tumor-specific ...